Related Experiment Videos
Polycation-based DNA complexes for tumor-targeted gene delivery in vivo
R Kircheis1, S Schüller, S Brunner
1Boehringer Ingelheim Austria, Vienna, Austria.
The Journal of Gene Medicine
|March 30, 2000
Summary
Targeted gene delivery in vivo is challenging. Researchers found that controlling nanoparticle properties like size and charge enables efficient, specific gene transfer to tumors, minimizing toxicity for gene therapy applications.
Area of Science:
- Gene Therapy
- Nanomedicine
- Molecular Biology
Background:
- In vivo gene delivery for gene therapy faces significant hurdles compared to cell culture.
- Obstacles include anatomical constraints, biological fluid interactions, and non-target cell binding.
Purpose of the Study:
- To evaluate polycation-based vectors for targeted gene delivery into tumors.
- To compare local and systemic application methods for gene delivery efficacy.
Main Methods:
- Adenovirus-enhanced transferrinfection (AVET) and transferrin-polyethylenimine (Tf-PEI) vectors were tested.
- DNA biodistribution and reporter gene expression were analyzed in tumors and major organs.
Main Results:
- Intratumoral application showed 10-100x higher gene transfer efficiency with Tf-PEI/DNA or AVET compared to naked DNA.
- Systemic delivery to tumors was successful with neutral AVET and PEGylated Tf-PEI/DNA complexes.
- Positively charged complexes led to lung gene expression and toxicity.
Conclusions:
- Physical and colloidal properties (size, stability, charge) of transfection complexes are critical for systemic gene delivery.
- Controlling these parameters allows targeted DNA biodistribution and gene expression in specific organs.